Funderburg NT, Xu D, Playford MP, Joshi AA, Andrade A, Kuritzkes DR, Lederman
MM, Mehta NN. Treatment of HIV infection with a raltegravir-based regimen
increases LDL levels, but improves HDL cholesterol efflux capacity. Antivir Ther.
2017;22(1):71-75. doi: 10.3851/IMP3091. Epub 2016 Oct 14. PubMed PMID: 27740536;
PubMed Central PMCID: PMC5516727.
Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB,
Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell
SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN,
Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL. Risk of End-Stage
Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017
Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12. PubMed PMID:
28497525; PubMed Central PMCID: PMC5489376.
Nixon DE, Bosch RJ, Chan ES, Funderburg NT, Hodder S, Lake JE, Lederman MM,
Klingman KL, Aberg JA; AIDS Clinical Trials Group Study A5275 Team. Effects of
atorvastatin on biomarkers of immune activation, inflammation, and lipids in
virologically suppressed, human immunodeficiency virus-1-infected individuals
with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group
Study A5275). J Clin Lipidol. 2017 Jan - Feb;11(1):61-69. doi:
10.1016/j.jacl.2016.09.017. Epub 2016 Oct 5. PubMed PMID: 28391912; PubMed
Central PMCID: PMC5407297.
Bonar MM, Tilton JC. High sensitivity detection and sorting of infectious
human immunodeficiency virus (HIV-1) particles by flow virometry. Virology. 2017
May;505:80-90. doi: 10.1016/j.virol.2017.02.016. Epub 2017 Feb 21. PubMed PMID:
28235684; PubMed Central PMCID: PMC5393045.
Garcia-Mesa Y, Jay TR, Checkley MA, Luttge B, Dobrowolski C, Valadkhan S,
Landreth GE, Karn J, Alvarez-Carbonell D. Immortalization of primary microglia: a
new platform to study HIV regulation in the central nervous system. J Neurovirol.
2017 Feb;23(1):47-66. doi: 10.1007/s13365-016-0499-3. Epub 2016 Nov 21. PubMed
PMID: 27873219; PubMed Central PMCID: PMC5329090.
Al-Kindi SG, Kim CH, Morris SR, Freeman ML, Funderburg NT, Rodriguez B,
McComsey GA, Dalton JE, Simon DI, Lederman MM, Longenecker CT, Zidar DA. Brief
Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular
Disease Risk in Patients With HIV Infection. J Acquir Immune Defic Syndr. 2017
Mar 1;74(3):298-302. doi: 10.1097/QAI.0000000000001231. PubMed PMID: 27828877;
PubMed Central PMCID: PMC5303143.
Al-Kindi SG, Zidar DA, McComsey GA, Longenecker CT. Association of
Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV.
Pathog Immun. 2017;2(1):138-150. doi: 10.20411/pai.v2i1.199. Epub 2017 May 2.
PubMed PMID: 28713869; PubMed Central PMCID: PMC5505669.
Fatukasi TV, Cole SR, Moore RD, Mathews WC, Edwards JK, Eron JJ; CNICS
investigators. Risk factors for delayed antiretroviral therapy initiation among
HIV-seropositive patients. PLoS One. 2017 Jul 10;12(7):e0180843. doi:
10.1371/journal.pone.0180843. eCollection 2017. PubMed PMID: 28700693; PubMed
Central PMCID: PMC5507276.
Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder
GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey
S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT,
Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore
RD, Crane HM. Increased Risk of Myocardial Infarction in HIV-Infected Individuals
in North America Compared With the General Population. J Acquir Immune Defic
Syndr. 2017 Aug 15;75(5):568-576. doi: 10.1097/QAI.0000000000001450. PubMed PMID:
28520615; PubMed Central PMCID: PMC5522001.
Belaunzarán-Zamudio PF, Azzoni L, Canaday DH, Caro-Vega YN, Clagget B, Rassool
MS, Rodriguez B, Sanne I, Sereti I, Sierra-Madero JG, Lederman MM. Immunologic
Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia
Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. Pathog Immun.
2017;2(2):151-177. doi: 10.20411/pai.v2i2.181. Epub 2017 May 9. PubMed PMID:
28736763; PubMed Central PMCID: PMC5518704.
Alan Levine awarded grant to determine if the combination of the human immunodeficiency virus (HIV) and drug abuse is a double kick in the gut.
They discovered that byproducts of bacteria in gum disease, called metabolic small chain fatty acid (SCFA), can work together to wake up HIV in dormant T-cells and cause the virus to replicate.
The research of Jonathan Karn, professor and chairman of molecular biology and microbiology, is one of four recipients of a $250,000 grant awarded earlier this year by amfAR. The national advocacy group raises money for HIV/AIDS research, education, prevention and treatment programs. Karn is heading up research on HIV latency.
Li Q, Karim AF, Ding X, Das B, Dobrowolski C, Gibson RM, Quinones-Mateu ME, Karn J, et al.
Pandiyan P, Talla A, McDonald D, Levine AD, Weinberg A, Sekaly RP, et al.
Cuca YP, Asher A, Okonsky J, Kaihura A, Dawson-Rose C, Webel A.